Related Experiment Video
Updated: Sep 25, 2025

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis
Zeshen Wu1,2,3, Yulu Peng1,2,3, Longbin Xiong1,2,3
1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Abstract:
Sunitinib is one of the first-line targeted drugs for metastatic renal cell carcinoma (RCC) with dual effects of antiangiogensis and proapoptosis. Sam68 (Src-associated in mitosis, 68 KDa), is found being involved in cell apoptosis. This article reveals that Sam68 impacts the sensitivity to sunitinib by mediating the apoptosis of RCC cells. Immunohistochemical staining indicated that the Sam68 expression levels in sunitinib sensitive tumor tissues were markedly higher than those in sunitinib resistant tumor tissues. Sunitinib induced RCC cell apoptosis in a concentration-dependent manner and inhibited the expression of total and phosphorylated Sam68 (p-Sam68). Downregulation of Sam68 expression inhibited RCC cell apoptosis induced by sunitinib. While upregulation of Sam68 expression could enhance apoptosis induced by sunitinib. Xenograft models showed that tumors in the Sam68-knockdown group did not shrink as much as those in the control group after treatment with sunitinib for 4 weeks. Together, our results suggest that Sam68 expression is associated with the sensitivity of ccRCC patients to sunitinib. Sam68 may promote cell apoptosis induced by sunitinib, and the Sam68 expression level may be a biomarker for predicting sunitinib sensitivity in ccRCC patients.
Insights
Sam68 protein levels influence treatment outcomes for metastatic renal cell carcinoma (RCC). Higher Sam68 expression enhances sunitinib-induced apoptosis, suggesting it may predict patient response to this targeted therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Sunitinib is a first-line targeted therapy for metastatic renal cell carcinoma (RCC), acting via antiangiogenesis and proapoptosis.
- Sam68 (Src-associated in mitosis, 68 KDa) is implicated in cellular apoptosis pathways.
Purpose of the Study:
- To investigate the role of Sam68 in mediating RCC cell apoptosis and its impact on sunitinib sensitivity.
- To determine if Sam68 expression levels can serve as a predictive biomarker for sunitinib efficacy in ccRCC patients.
Main Methods:
- Immunohistochemical staining of tumor tissues to compare Sam68 expression in sunitinib-sensitive versus resistant RCC.
- In vitro experiments assessing sunitinib-induced apoptosis and Sam68 expression (total and phosphorylated) in RCC cells.
- In vivo studies using xenograft models with Sam68-knockdown and control groups treated with sunitinib.
Main Results:
- Sam68 expression was significantly higher in sunitinib-sensitive RCC tissues compared to resistant tissues.
- Sunitinib induced RCC cell apoptosis in a dose-dependent manner, concurrently inhibiting Sam68 expression.
- Downregulating Sam68 reduced sunitinib-induced apoptosis, while upregulating Sam68 enhanced it. Xenograft tumors in Sam68-knockdown mice showed less shrinkage with sunitinib treatment.
Conclusions:
- Sam68 expression is correlated with ccRCC patient sensitivity to sunitinib.
- Sam68 promotes sunitinib-induced apoptosis in RCC cells.
- Sam68 levels may serve as a predictive biomarker for sunitinib response in ccRCC.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...